Zefei Jiang

Nov 4, 2023 | acsjournals.onlinelibrary.wiley.com | Jianbin Li |Zefei Jiang

INTRODUCTION Targeted therapy has become a crucial strategy for the treatment of patients with breast cancer. Improving the ability to recognize tumor cells with specific antigens and increasing tumor-killing activation and effectiveness have become major goals in drug discovery. Antibody drug conjugates (ADCs) are novel drugs that exert specific cytotoxicity against tumor cells.